Guidance on Qualification of existing facilities, systems, equipment and utilities



Similar documents
Working Party on Control of Medicines and Inspections. Final Version of Annex 15 to the EU Guide to Good Manufacturing Practice

GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS ANNEX 15 *

OPERATIONAL STANDARD

PROPOSAL FOR REVISION OF THE SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES: VALIDATION, APPENDIX 7: NON-STERILE PROCESS VALIDATION

Annex 2. WHO good manufacturing practices for pharmaceutical products: main principles 1

Calibration & Preventative Maintenance. Sally Wolfgang Manager, Quality Operations Merck & Co., Inc.

Testing Automated Manufacturing Processes

In 2001, ISPE issued Baseline Guide Volume

Validation and Calibration. Definitions and Terminology

Quality Assurance. Disclosure for Lilli Møller Andersen. No relevant financial relationships exist for any issue mentioned in this presentation

Process Validation: Practical Aspects of the New FDA Guidance

Quality Risk Management Tools Quality Risk Management Tool Selection When to Select FMEA: QRM Tool Selection Matrix

Cleaning Validation in Active pharmaceutical Ingredient manufacturing plants

ICH guideline Q10 on pharmaceutical quality system

ASSESSMENT OF QUALITY RISK MANAGEMENT IMPLEMENTATION

PROPOSED UPDATED TEXT FOR WHO GOOD MANUFACTURING PRACTICES FOR PHARMACEUTICAL PRODUCTS: MAIN PRINCIPLES (JANUARY 2013)

Annex 9 Guide to good storage practices for pharmaceuticals 1

International GMP Requirements for Quality Control Laboratories and Recomendations for Implementation

SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES (GMP): VALIDATION

Annex 4 Good Manufacturing Practices for pharmaceutical products: main principles

Process Validation for Medical Devices

Best Practice In A Change Management System

MHRA GMP Data Integrity Definitions and Guidance for Industry March 2015

Quality Risk Management

Implementing New USP Chapters for Analytical Method Validation

Annex 7 Guidelines on pre-approval inspections

QUALITY RISK MANAGEMENT (QRM): A REVIEW

Commercial Manufacturing - Qualification & Validation-related GMP Deficiencies and Other Lifecycle Considerations

PHARMACEUTICAL QUALITY SYSTEM Q10

Step-by-Step Analytical Methods Validation and Protocol in the Quality System Compliance Industry

AN OVERVIEW OF PHARMACEUTICAL VALIDATION: QUALITY ASSURANCE VIEW POINT

QUALITY RISK MANAGEMENT

Considerations When Validating Your Analyst Software Per GAMP 5

MHRA GMP Data Integrity Definitions and Guidance for Industry January 2015

FAT Factory Acceptance Testing SAT Site Acceptance Testing

Impact Assessment in a Science & Risk Based Environment. R. Legland 11/04/11

Corrective and Preventive Actions

Checklist. Standard for Medical Laboratory

White paper: FDA Guidance for Industry Update Process Validation

Quality Risk Management The Pharmaceutical Experience Ann O Mahony Quality Assurance Specialist Pfizer Biotech Grange Castle

The purpose of this Supplier Quality Standard is to communicate the expectations and requirements of Baxter Healthcare Corporation to its suppliers.

Computer System Validation - It s More Than Just Testing

EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union.

Installation and Operational Qualification Protocol (Reference: SOP )

Audit Report in the framework of the APIC Audit Programme

Guidelines for Validation & Qualification, including Change Control, for Hospital Transfusion Laboratories

Working Party on Control of Medicines and Inspections. Final Version of Annex 16 to the EU Guide to Good Manufacturing Practice

Title:: Effective GMP AUDITS for APIs and Formulation Pharma Companies By G.Sundar-Director/Consultant PharmQA Compliance solutions

Qualification of temperature-controlled storage areas

INTRODUCTION. This book offers a systematic, ten-step approach, from the decision to validate to

Comparative analysis between the possible regulatory approaches to GMP compliance TITOLO PRESENTAZIONE

(WHO Technical Report Series, No. 961, 2011), Annex 9. Temperature and humidity monitoring systems for fixed storage areas 107

Quality Management System (QMS) for Active Pharmaceutical Ingredients (API) Manufacturers

Guideline on Process Validation

Annex 4 Supplementary guidelines on good manufacturing practices: validation

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union

Combination Products. Presented by: Karen S. Ginsbury For: IFF March PCI Pharma

Annex 1 WHO good practices for pharmaceutical quality control laboratories

IMP management at site. Dmitry Semenyuta

JANUARY 2013 PREPARATION OF A SITE MASTER FILE FOR A MANUFACTURER OF COSMETIC PRODUCTS

High Potent Drugs & Containment Technology

Guidance for Industry. Q10 Pharmaceutical Quality System

COMPLIANCE BY DESIGN FOR PHARMACEUTICAL QUALITY CONTROL LABORATORIES INSIGHT FROM FDA WARNING LETTERS

ISO/IEC QUALITY MANUAL

Quality Agreement. by and between. Supplier Name. Address: and. Client Name: Address:

Guidance for Industry

UNICEF s Quality Assurance System for procurement of medicines

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex. The Rules Governing Medicinal Products in the European Union

GUIDELINE ON ACTIVE PHARMACEUTICAL INGREDIENT MASTER FILE (APIMF) PROCEDURE 1 (The APIMF procedure guideline does not apply to biological APIs.

Quality Risk Management ICH Q9 & ISO Presented by Michael Kerr 11 th November 2011

ICH guideline Q8, Q9 and Q10 - questions and answers volume 4

Annex 2. WHO guidelines on quality risk management. 1. Introduction Glossary Quality risk management process 70

Quality assurance of pharmaceuticals

Computerised Systems. Seeing the Wood from the Trees

Computer validation Guide. Final draft

Installation, Operation and Performance Qualification of a Thermoguard Installation

FDA Guidance for Industry Update - Process Validation

VALIDATION OF ANALYTICAL PROCEDURES: TEXT AND METHODOLOGY Q2(R1)

Application of Quality Risk Management to Pharmaceutical Operations. Eldon Henson, Vice President, Quality Operations

A Quality System Approach to Retrospective Validation of Manufacturing Support Systems William Lodato, P.E.

QUALITY ASSURANCE AND INTELLECTUAL PROPERTY RIGHTS

3.4.4 Description of risk management plan Unofficial Translation Only the Thai version of the text is legally binding.

COMMISSION DIRECTIVE 2003/94/EC

Session 6: WHO Prequalification Programme. Key Process Steps WHO: Medicines UNFPA: Condoms and IUDs

Comparison of EU GMP guidelines with WHO guidelines Identification of the cost-intensive requirements

ACTIVE PHARMACEUTICAL INGREDIENTS COMMITTEE

Measuring instruments in industry.

ASTRAZENECA GLOBAL POLICY QUALITY AND REGULATORY COMPLIANCE

Library Guide: Pharmaceutical GMPs

Implementing Lifecycle Validation Practices at Contract Manufacturing Organizations

OVERVIEW OF STANDARD 7E & STANDARD 20

Process Validation Protocol (Reference: SOP )

OMCL Network of the Council of Europe QUALITY ASSURANCE DOCUMENT

1. Scope This SOP covers requirements for PHARMCO-AAPER s Quality Management System

Recent Updates on European Requirements and what QPs are expected to do

The FDA recently announced a significant

GAMP5 - a lifecycle management framework for customized bioprocess solutions

GAMP 5 and the Supplier Leveraging supplier advantage out of compliance

SPECIFICATIONS AND CONTROL TESTS ON THE FINISHED PRODUCT

Transcription:

QUALIFICATION_EXISTING_EQUIPMENT_FINAL page 1 / 16

1. Acknowledgement...3 2. Introduction...3 3. Scope...4 4. Regulatory requirements...4 5. Guidance...4 5.1 Risk Assessment... 4 5.2 Procedure... 7 5.3 Tables and flow charts... 8 5.3.1 Flow Scheme...8 5.3.2 Table...9 5.3.3 Example of Documentation matrix...10 5.3.4 Example of Qualification matrix...11 5.3.4.1 IQ... 11 5.3.4.2 OQ/PQ... 12 6. References...13 7. Appendices...13 QUALIFICATION_EXISTING_EQUIPMENT_FINAL page 2 / 16

1. Acknowledgement This document was prepared by a Task Force consisting of representatives from various companies within the Active Pharmaceutical Ingredients industry that participate in the API Committee of CEFIC. We thank all the members mentioned below for their efforts, cooperation, creativeness, constructive comments and endurance. Without these elements this document would not have reached its present status. The members of this Task Force are: Claude Vandenbossche (Ajinomoto-OmniChem NV) David Halsted (AstraZeneca) Isabelle Blancho (Roquette Frères SA) Massimiliano Brescia (Abbott Laboratories) Ricardo Giralt (Boehringer Ingelheim) Stefan Gangkofner (CU Chemie Uetikon GmbH) Willy Verhaegen (Ajinomoto-OmniChem NV) Wolter de Vries, chairman (Diosynth) 2. Introduction Detailed guidance for the qualification of new equipment is given in existing guidelines (see References). However APIC recognized there is only limited guidance with respect to the qualification of existing equipment. Therefore APIC has prepared a document to reflect current thinking of the API manufacturing industry on this matter. It is not unusual to find that an existing facility has a mixture of new fully qualified equipment (DQ, IQ, OQ, PQ) and partially qualified / unqualified equipment. Through many years of use, it can usually be shown that facilities, systems, equipment and utilities can function to varied requirements. Nevertheless, cs necessitate that, items which have impact on the quality of the intermediate or API, should be qualified. Formal qualification is the basis for the related activities such as validation associated with new product introduction or validation of existing processes. It forms the starting point for future change control. Qualification should provide documented verification that the parameters defined as critical for operation and maintenance are adequately controlled. It is essential that the qualification is practical and achievable, adds value to the project and is concentrated on the critical elements of the system. It is recommended that a risk assessment approach is used to define the depth of qualification. There should always be a reasonable proportionality between risk for the product quality, the amount of measures to be taken and documentation to be prepared (.e.g. stage of manufacture, regulatory status and intended use). QUALIFICATION_EXISTING_EQUIPMENT_FINAL page 3 / 16

3. Scope This guide is intended for use by manufacturers of Active Pharmaceutical Ingredients (APIs) and API intermediates that use equipment and utilities. This guide is applicable to all stages from the API Starting Material onwards, which can influence product quality. However earlier stages could be considered. 4. Regulatory requirements The ICH Q7a (see Reference 1) requirement is that facilities, systems, equipment and utilities are properly qualified and maintained to assure data and product integrity. Additional guidance is provided by PIC/S: While it is not possible to undertake the details of an Installation Qualification for established equipment nor the detailed approach for an Operational Qualification, nevertheless there should be data available that support and verify the operating parameters and limits for the critical variables of the operating equipment. Additionally, the calibration, cleaning, preventative maintenance, operating procedures and operator training procedures for the use of the equipment should be documented and in use as standard operating procedures (SOPs). (see Reference 3). 5. Guidance 5.1 Risk Assessment This section describes the principle of Risk Assessment (RA) as applied to plant qualification. The next section (5.2 Procedure ) describes the recommended activities required to qualify existing equipment including when to use the RA process. RA is a formal and systematic approach to identify risks related to equipment and supporting systems. It is a very helpful tool that can be applied to plant, equipment and systems which have been in use for many years. It is recommended that the manufacturing instructions are used in combination with general requirements (e.g. design, documentation, risk for contamination, usage in final dosage form etc.) as the basis for the risk assessment. Each manufacturing step can be assessed individually with respect to critical operations / activities (e.g. stirring speeds, temperature ranges, pressure, hygroscopy, open product handling etc.). Process descriptions, development reports, product quality reviews and process validation reports can assist in identifying the quality critical operations and parameters. Risk Assessment can be carried out using different approaches e.g. HAZOP, FMEA, decision tree etc. Equipment risk assessment can be performed by equipment train or by individual processing units (individual reactor, individual centrifuge, etc.) and supporting systems. A grouping strategy of similar/identical processing units can be used. QUALIFICATION_EXISTING_EQUIPMENT_FINAL page 4 / 16

Unit operations or functions could be assessed according to the following scheme: Does Function / Operation directly impact product quality? Does Function / Operation create (electronic) data which are the basis for related activities? Would malfunction impact directly on product quality? Does a measuring instrument control or measure quality critical processing steps / parameters? Does Operation / Installation causes contamination risk of product or of the facility environment? Are materials of construction in direct contact with product? If any of the above questions are answered with yes, the operation / function is considered as -relevant. During risk assessment, the probability of occurrence and detectability should be considered and measures to reduce the risk identified. An example for a technical risk assessment is given below: Objective of the risk assessment - Identification of potential risks related to products, preventive / corrective actions and checks related to qualification. Scope - Identification of processing unit and location. QUALIFICATION_EXISTING_EQUIPMENT_FINAL page 5 / 16

General - Description of the processing unit (size, configuration, supporting systems (heating / cooling / vacuum / nitrogen / solvents etc.), type of products produced (e.g. APIs, API intermediates, drug product application, etc.), possible connections with other processing units (like filters, centrifuges, supporting systems, containers, gases, water systems, waste gases etc.), System boundaries - Description of what will be addressed during the risk assessment. Related documents / baseline documents for risk assessment - P&IDs, engineering documents, SOPs, deviations. The risk assessment can be performed using a template, where typical working steps / activities for the processing units are listed (including instrumentation and control systems). An example is given below for a reactor: - stirring - crystallisation - supporting systems - heating / cooling - charging / discharging - evacuation - sampling - etc. Additionally, materials of construction with direct product contact are assessed and critical measuring `and control devices are identified that need to be calibrated. QUALIFICATION_EXISTING_EQUIPMENT_FINAL page 6 / 16

5.2 Procedure It is recommended that the following activities are carried out during qualification of existing equipment: 1. Collect flow diagrams and matrixes which can be useful in providing an overview and monitoring tool. A flow scheme for the introduction of a new product into an existing plant is shown (see 5.3.1). 2. Refer to the table (see 5.3.2) which indicates the activities in the qualification. 3. Prepare a Validation Master Plan (VMP) and/or Qualification Plan (QP) (see Definitions). A section of the Validation Master Plan should cover the qualification of plant and equipment [see Reference 4]. 4. Collect, review and update related documentation to the equipment (procedures, change control, historical production data, process deviations). This activity may be done using a documentation matrix (example) as shown in 5.3.3. 5. Execute the Risk Assessment Process to identify which items of equipment require qualification (see 5.1). The Risk Assessment Process will be carried out on every system or sub-system. 6. Prepare a Qualification Matrix for IQ (see 5.3.4.1). 7. Update the detailed line diagram of the plant by checking it against the physical plant. The existing Installation Qualification (IQ) and engineering files should be reviewed and updated. 8. Prepare a further Qualification Matrix to review the accuracy and range of equipment/ instruments and identify items requiring OQ and PQ (see 5.3.4.2). 9. Perform the OQ and PQ to complete the qualification. 10. Ongoing change management should be implemented after reporting and approval of all activities in the VMP and/or QP. QUALIFICATION_EXISTING_EQUIPMENT_FINAL page 7 / 16

5.3 Tables and flow charts 5.3.1 Flow Scheme Please refer to the next table (5.3.2) for the numbering key. Prepare Validation Master Plan (1) Qualification Plan Execute Risk Assessment (2) - Prepare Qualification Matrix (3) - Rev iew historical documents, deviations, production data (4) - Prepare Documentation Matrix (4) Do plant items have all IQ documents? No Update P&ID and related documents Yes All IQ requirements are now in place? No Perform IQ Yes Is OQ already available? No Perform OQ Yes Perform PQ (5) Update the procedures around the equiment/system (6) Prepare ValidationReport//Qualification Report (7) Qualification complete Basi s of on-going Change Control (8) QUALIFICATION_EXISTING_EQUIPMENT_FINAL page 8 / 16

5.3.2 Table Flow Scheme of Activities in the Qualification Activity Examples Document 1 Define qualification scope VMP (QP) including systems and equipment 2 Execute Risk Assessment (RA) RA matrix 3 Set-up of a Qualification Matrix with all systems, components Qualification Matrix (IQ) 4 Review historical documents and production data - Datasheet(s) / Technical Description / Certificates (e.g. material of construction) - Drawing(s) - Parts list(s) - Installation instructions - Operating instructions - Maintenance instructions and records - Calibration instructions and records - Copy of supplier s proposal, order and order confirmation - Commissioning and test plans - Electrical diagrams - Batch records and analytical results and plant parameter data Engineering Files and Documentation Matrix Process Validation and Production Campaign Reports Collect and review all historical deviations, changes related to equipment/systems and failures if available Reviewing the available procedures around the equipment/system 5 Review the qualification/accuracy of equipment and implement OQ/PQ 6 Updating the available procedures around the equipment/system 7 Prepare Validation Report / Qualification Report 8 Have basis for on-going Change Control - Deviation Reports Change Reports Complaint Files - Maintenance, calibration procedures OQ, PQ Maintenance, calibration and operating procedures. Evaluation Report Annual Product Review SOP s and working instructions Qualification Matrix (OQ, PQ) SOP s and working instructions Validation Master Report (or equivalent reports) QUALIFICATION_EXISTING_EQUIPMENT_FINAL page 9 / 16

5.3.3 Example of Documentation matrix Equipment identification Location Manufacturer Model Serial number Document type Required (YES/NO) Availability (YES/NO) Document nr Comments User Requirement P&ID and Lay-out Manufacturing Drawing Wiring Diagram Operating Manual Technical Specification Factory Acceptance Tests Site Acceptance Tests Operating Procedure Maintenance Procedure Instruments Calibration Qualification Protocol Inspection Report (Safety Requirement) Materials certification Cleaning/Sanitation Training Supplier Audit Hardware Design/ Functional Specification Software Design /Software Specification Traceability Matrix (UR>FS>Test) Further information to be considered are the following: a) operating time b) analytical trends c) maintenance history d) deviations/non-conformities e) systems under change control f) equipment logbook QUALIFICATION_EXISTING_EQUIPMENT_FINAL page 10 / 16

5.3.4 Example of Qualification matrix 5.3.4.1 IQ Plant Items / no. Quality Impact? Y / N IQ Required / doc. No. Direct Indirect No Impact Y N N Y Reactor RE1.3.x Reactor RE1.4.x Y N N Y Centrifuge CE2.4.x Y N N Y Dryer DR3.3.x Chilling Unit CU4.2.x Waste Receiver WR5.7.x Y N N Y N Y N N N N Y N QUALIFICATION_EXISTING_EQUIPMENT_FINAL page 11 / 16

5.3.4.2 OQ/PQ Plant Items / Operations / no. Parameters Type Range Accuracy Test by OQ / doc. No. Test by PQ / doc. No. Reactor RE4.3.x Temperature -20/180 o C ± 2 o C Y Y Reactor RE4.4.x Vacuum 50m bar ± 20mbar N Y Weigh Scale WS10.3.x Weigh Scale WS10.4.x Solvent Meter SM14.6.x Weight 0/1500Kg ±1.0 Kg N* N Weight 0/2000 Kg ± 1.0 Kg N* N Volume 130L ±2.0L N* N Reactor RE2.1.x Temperature 20/180 o C ± 2 o C Y Y * The weigh scale and solvent meter has still to be calibrated. QUALIFICATION_EXISTING_EQUIPMENT_FINAL page 12 / 16

6. References 1. Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients. ICH Harmonized Tripartite Guideline. 2000 (Q7a) 2. I.S.P.E. Pharmaceutical Engineering Guide for New and Renovated Facilities, Vol. 5 Commissioning and Qualification, March 2001 3. PIC/S Recommendations on Validation Plan, Installation and Operational Qualification, Non-Sterile Process Validation, Cleaning Validation, August 2001. 4. EC Guide to, Annex 15 Qualification and Validation. 7. Appendices 1. Glossary and Abbreviations QUALIFICATION_EXISTING_EQUIPMENT_FINAL page 13 / 16

1. Glossary and Abbreviations Active Pharmaceutical Ingredient (API) Any substance or mixture of substances intended to be used in the manufacture of a drug (medicinal) product and that, when used in the production of a drug, becomes an active ingredient of the drug product. Such substances are intended to furnish pharmacological activity or other direct effect in the diagnosis, cure, mitigation, treatment, or prevention of disease or to affect the structure and function of the body. Computer System A group of hardware components and associated software, designed and assembled to perform a specific function or group of functions. Concurrent Validation The validation carried out during routine production of products intended for sale Critical Describes a process step, process condition, test requirement, or other relevant parameter or item that must be controlled within predetermined criteria to ensure that the API meets its specification. Direct impact system The performance of this type of system has a direct and measurable effect (= impact) on the quality of the product. A system determined to be a direct impact system must be designated as such and maintained per approved procedures. Design Qualification (DQ) Documented verification that the proposed design of the facilities, systems and equipment is suitable for the intended purpose. FMEA Failure mode and effect analysis. HAZOP Hazard and Operability studies. Installation Qualification (IQ) Documented verification that the equipment or systems, as installed or modified, comply with the approved design, the manufacturer s recommendations and/or user requirements. Operational Qualification (OQ) Documented verification that the equipment or systems, as installed or modified, perform as intended throughout the anticipated operating ranges. QUALIFICATION_EXISTING_EQUIPMENT_FINAL page 14 / 16

Performance Qualification (PQ) Documented verification that the equipment and ancillary systems, as connected together, can perform effectively and reproducibly based on the approved process method and specifications. Process Validation (PV) The documented evidence that the process, operated within established parameters, can perform effectively and reproducibly to produce a medicinal product meeting its predetermined specifications and quality attributes. Prospective Qualification Documented evidence that the equipment and ancillary systems, will consistently function according to pre-determined acceptance criteria. It should be finished before the process validation starts. Retrospective Qualification The qualification process (of existing equipment) is carried out when the routine production is already started. Prospective Validation The validation is carried out before routine production of products intended for sale. Retrospective Validation The validation of a process for a product that has been marketed based upon accumulated manufacturing, testing and control batch data. Risk Assessment (RA) A comprehensive evaluation of the risk and its associated impact. System A number of integrated steps, functions and items of equipment that must be considered as a unit in order to assure supply of consistent, uniform and high quality components for the manufacturer of a product. Unit A part of a processing system that has the ability to carry out independent processing. Validation A documented program that provides a high degree of assurance that a specific process, method, or system will consistently produce a result meeting pre-determined acceptance criteria. Validation Master Plan (VMP) A high level document, which establishes an umbrella validation plan for the entire project and is used as guidance to the project team for resource and technical planning. QUALIFICATION_EXISTING_EQUIPMENT_FINAL page 15 / 16

Qualification Plan (QP) A high level document which defines the activities associated with the qualification of equipment and may be a part of the VMP. QUALIFICATION_EXISTING_EQUIPMENT_FINAL page 16 / 16